
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
latest_posts
- 1
Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza - 2
Why home maintenance deserves a spot in the annual health and budget plans - 3
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump - 4
Sentimental tree to shine at Arctic League annual broadcast - 5
IDF, police arrest eleven for criminal, terror-related activity over weekend
NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery
10 Natural products to Remember for Your Eating routine for a Better You
Brazil passes anti-gang law allowing seized crypto to fund security forces
A Manual for the Right SUV for Seniors
You finally got a doctor's appointment. Here's how to get the most out of it
Investigating the Financial History of the World: A Succinct Outline
Former biotech CEO sued over COVID vaccine alleged insider trading
Scientists are getting our robotic explorers ready to help send humans to Mars
Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns













